We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+10.34%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$23.5B
AUM Growth
+$2.05B
Cap. Flow
-$1.67M
Cap. Flow %
-0.01%
Top 10 Hldgs %
21.02%
Holding
3,355
New
222
Increased
1,262
Reduced
1,627
Closed
171

Sector Composition

Rank Sector Weight
1 Technology 10.74%
2 Financials 4.97%
3 Consumer Discretionary 4.15%
4 Healthcare 3.65%
5 Industrials 2.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLQT icon
3151
SelectQuote
SLQT
$124M
$15K ﹤0.01%
10,992
AKTS
3152
DELISTED
Akoustis Technologies Inc
AKTS
$15K ﹤0.01%
17,423
-2,019
-10% -$1.36K
DXYN
3153
DELISTED
Dixie Group Inc
DXYN
$15K ﹤0.01%
20,000
SCWO icon
3154
374Water
SCWO
$40.6M
$14K ﹤0.01%
1,000
WKHS icon
3155
Workhorse Group
WKHS
$33.7M
$14K ﹤0.01%
13
-2
-13% -$2.39K
CLOV icon
3156
Clover Health Investments
CLOV
$2.41B
$13K ﹤0.01%
14,099
-2,096
-13% -$2.06K
QVCGA
3157
DELISTED
QVC Group Inc Series A
QVCGA
$13K ﹤0.01%
289
-242
-46% -$8.29K
CLSD
3158
DELISTED
Clearside Biomedical
CLSD
$12K ﹤0.01%
700
-400
-36% -$5.7K
DM
3159
DELISTED
Desktop Metal, Inc.
DM
$12K ﹤0.01%
1,584
-3,264
-67% -$29.6K
VLD
3160
DELISTED
Velo3D, Inc.
VLD
$12K ﹤0.01%
871
+56
+7% +$2.15K
OMIC
3161
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$12K ﹤0.01%
878
PHIO icon
3162
Phio Pharmaceuticals
PHIO
$12.5M
$11K ﹤0.01%
1,581
SHCR
3163
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
$11K ﹤0.01%
10,200
DOYU
3164
DouYu International Holdings
DOYU
$138M
$10K ﹤0.01%
1,050
INO icon
3165
Inovio Pharmaceuticals
INO
$79.6M
$10K ﹤0.01%
1,635
-73
-4% -$360
VAXX
3166
DELISTED
Vaxxinity, Inc. Class A Common Stock
VAXX
$10K ﹤0.01%
12,000
SENS icon
3167
Senseonics Holdings Inc
SENS
$419M
$9K ﹤0.01%
826
ORGS
3168
DELISTED
Orgenesis Inc. Common Stock
ORGS
$9K ﹤0.01%
1,833
ACB
3169
Aurora Cannabis
ACB
$237M
$7K ﹤0.01%
1,517
-28
-2% -$135
SOLO
3170
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
$6K ﹤0.01%
17,288
-4,900
-22% -$2.06K
TPET icon
3171
Trio Petroleum
TPET
$11.2M
$5K ﹤0.01%
750
EGIO
3172
DELISTED
Edgio, Inc. Common Stock
EGIO
$5K ﹤0.01%
340
-2
-0.6% -$49
VWE
3173
DELISTED
Vintage Wine Estates, Inc. Common Stock
VWE
$5K ﹤0.01%
10,800
INSG icon
3174
Inseego
INSG
$82.6M
$4K ﹤0.01%
+1,598
New +$4.81K
SMR.WS
3175
DELISTED
NuScale Power Corporation Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
SMR.WS
$4K ﹤0.01%
+12,500
New +$5.22K

Similar funds

Cambridge Investment Research Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, Cambridge Investment Research Advisors held 3,355 positions worth $23.5B, up 9.6% from $21.4B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Cambridge Investment Research Advisors's Q4 2023 filing shows 222 new, 1,262 increased, 1,627 reduced and 171 closed positions. Its largest new stake was Innovator Equity Managed Floor ETF: 254,744 shares worth $6.96M. The largest sale was iShares 0-1 Year Treasury Bond ETF, an estimated $62.7M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Cambridge Investment Research Advisors's largest Q4 2023 buy was Innovator Equity Managed Floor ETF: 254,744 shares worth $6.96M.
  • Cambridge Investment Research Advisors added most to Invesco QQQ Trust in Q4 2023, an estimated $73.8M increase.
  • Cambridge Investment Research Advisors's biggest Q4 2023 reduction was iShares 0-1 Year Treasury Bond ETF, cutting an estimated $62.7M.
  • Cambridge Investment Research Advisors fully exited Invesco BulletShares 2023 Corporate Bond ETF in Q4 2023, selling an estimated $15M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 21% of its $23.5B portfolio in Q4 2023.
  • Cambridge Investment Research Advisors opened 222 new positions and closed 171 in Q4 2023.
  • Cambridge Investment Research Advisors's portfolio value rose 9.6% quarter-over-quarter to $23.5B.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2023, filed 9 Feb 2024.